業績

 

2011

Kitagawa H., Fujiki R., Yoshimura K., Oya H., Kato S.: Williams syndrome is an epigenome-regulator disease. Endocr J., 58(2):77-85. 

 

2010

 

Akimoto C., Ueda T., Yamaoka I., Inoue K., Sakari M.,Ohara K., Fujioka T., Nagahara A., Nonomura N., Tsutsumi S., Aburatani H., Miki T., Matsumoto T., Kitagawa H., Kato S.: TSPY represses the activity of the androgen receptor in androgen-dependent testicular germ cell tumors. Proc Natl Acad Sci U S A. 107(46):19891-6.

 

 

Matsuyama R, Takada I, Yokoyama A, Fujiyama-Nakamura S, Tsuji N, Kitagawa H, Fujiki R, Kim M, Kouzu-Fujita M, Yano T, Kato S.: Double PHJD fingers protein DPF2 recognizes acetylated histones and suppresses the function of ERR{alpha} through histone deacetylates 1. J.Biol.Chem. 285(24):18166-76.

 

 

Takada I, Tsuji N, Youn MY, Fujiyama S, Okada M, Imai Y, Kondo S, Kitagawa H, Yasuda H, Kato S.: Purification and identification of estrogen receptor alpha co-regulators in osteoclasts. Ann N Y Acad Sci. 192(1): 201-7.   

 

 

Ochiai E., Kitagawa H., Takada I., Fujiyama S., Sawatsubashi S., Kim M., Mezaki Y., Tshuushima Y., Takagi K., Yamaoka K., Kato S., Kamimura T.: CDP/Cut is an Osteoblastic Co-activator of the Vitamin D receptor (VDR) . J.Bone Miner Res. 25(5):1157-66.

 

 

Murai-Takeda A, Shibata H, Kurihara I, Kobayashi S, Yokota K, Suda N, Mitsuishi Y, Jo R, Kitagawa H, Kato S, Saruta T, Itoh H.: NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor., J. Biol. Chem., 285, 8084-93.

 

 

 

2009

 

Oya, H., Yokoyama, A.,Yamaoka, I., Fujiki, R., Yonezawa, M., Youn, M., Takada, I., Kato, S. & Kitagawa, H.: Phosphorylation of Williams syndrome transcription factor by MAPK induces a switching between two distinct chromatin remodeling complexes., J. Biol. Chem., 284, 32472-32482.

 

印はcorresponding author